Skip to main content
Intended for healthcare professionals
Restricted access
Research article
First published online August 1, 2019

Oral Diseases Associated with Nonalcoholic Fatty Liver Disease in the United States

Abstract

The US prevalence of nonalcoholic fatty liver disease (NAFLD) is 30.6% and increasing. NAFLD shares some risk factors with periodontitis and dental caries. We explored the association between NAFLD and several oral conditions among US adults, using data from the cross-sectional, nationally representative National Health and Nutrition Examination Survey (NHANES), 1988 to 1994. NAFLD was assessed with ultrasonography (USON), the screening gold standard not available in the more recent NHANES, and the noninvasive Fibrosis Score (FS), Fatty Liver Index (FLI), and US Fatty Liver Index (US-FLI) as other screening alternatives. There were 5,421 eligible dentate adults aged 21 to 74 y with complete relevant data, with transferrin levels ≤50%, without hepatitis B or C, who were not heavy drinkers. Multivariable models were developed to examine the independent effects of moderate-severe periodontitis, untreated dental caries, caries experience, and tooth loss (<20 teeth) on NAFLD while controlling for clinical, biological, and sociodemographic factors. Weighted estimates for odds ratios (ORs) and 95% CIs were calculated with logistic regression. Between 17% and 24% of adults had NAFLD depending on the classification criteria. In adjusted models, as compared with those with better oral health, adults with <20 teeth were more likely to have NAFLD depending on the measure (USON: OR = 1.50, 95% CI = 1.11 to 2.02; FS: OR = 4.36, 95% CI = 3.47 to 5.49; FLI: OR = 1.99, 95% CI = 1.52 to 2.59; US-FLI: OR = 2.32, 95% CI = 1.79 to 3.01). People with moderate-severe periodontitis were more likely to have NAFLD (USON: OR = 1.54, 95% CI = 1.06 to 2.24; FS: OR = 3.10, 95% CI = 2.31 to 4.17; FLI: OR = 1.61, 95% CI = 1.13 to 2.28; US-FLI: OR = 2.21, 95% CI = 1.64 to 2.98). People with any untreated caries were more likely to have NAFLD (USON: OR = 1.51, 95% CI = 1.20 to 1.90; FLI: OR = 1.80, 95% CI = 1.33 to 2.44). NAFLD was associated with tooth loss, periodontitis, and, for some NAFLD measures, untreated dental caries but not overall caries experience after controlling for several key sociodemographic and behavioral factors. Results suggest that further evaluation is needed to better understand this health–oral health interrelationship and potential opportunities for medical-dental integration.

Get full access to this article

View all access and purchase options for this article.

References

Akinkugbe AA, Barritt AS, Cai J, Offenbacher S, Thyagarajan B, Khambaty T, Singer R, Kallwitz E, Heiss G, Slade GD. 2017. Periodontitis and non-alcoholic fatty liver disease, a population-based cohort investigation in the Study of Health in Pomerania. J Clin Periodontol. 44(11):1077–1087.
Alakhali MS, Al-Maweri SA, Al-Shamiri HM, Al-Haddad K, Halboub E. 2018. The potential association between periodontitis and non-alcoholic fatty liver disease: a systematic review. Clin Oral Investig. 22(9):2965–2974.
Alazawi W, Bernabe E, Tai D, Janicki T, Kemos P, Samsuddin S, Syn WK, Gillam D, Turner W. 2017. Periodontitis is associated with significant hepatic fibrosis in patients with non-alcoholic fatty liver disease. PLoS One. 12(12):e0185902.
Angulo P, Hui JM, Marchesini G, Bugianesi E, George J, Farrell GC, Enders F, Saksena S, Burt AD, Bida JP, et al. 2007. The NAFLD fibrosis score: a noninvasive system that identifies liver fibrosis in patients with NAFLD. Hepatology. 45(4):846–854.
Aykut UE, Akyuz U, Yesil A, Eren F, Gerin F, Ergelen R, Celikel CA, Yilmaz Y. 2014. A comparison of FibroMeter NAFLD Score, NAFLD fibrosis score, and transient elastography as noninvasive diagnostic tools for hepatic fibrosis in patients with biopsy-proven non-alcoholic fatty liver disease. Scand J Gastroenterol. 49(11):1343–1348.
Ballestri S, Nascimbeni F, Baldelli E, Marrazzo A, Romagnoli D, Targher G, Lonardo A. 2017. Ultrasonographic fatty liver indicator detects mild steatosis and correlates with metabolic/histological parameters in various liver diseases. Metab Clin Exp. 72:57–65.
Bedogni G, Bellentani S, Miglioli L, Masutti F, Passalacqua M, Castiglione A, Tiribelli C. 2006. The fatty liver index: a simple and accurate predictor of hepatic steatosis in the general population. BMC Gastroenterol. 6:33.
Centers for Disease Control and Prevention. 2011. National Health and Nutrition Examination Survey, 1988–1994. Data documentation, codebook, and frequencies. Hepatic/gallbladder ultrasound and hepatic steatosis (HGUHS); [accessed 2018 Aug 22]. https://wwwn.cdc.gov/nchs/data/nhanes3/34a/HGUHS.htm#GUPCHSC.
Centers for Disease Control and Prevention. 2017a. About adult BMI. Atlanta, GA; Centers for Disease Control and Prevention; [accessed 2018 Oct 3]. https://www.cdc.gov/healthyweight/assessing/bmi/adult_bmi/index.html.
Centers for Disease Control and Prevention. 2017b. National Health and Nutrition Examination Survey, 1988–1994. Questionnaires, datasets, and related documentation; [accessed 18 Oct 2018]. https://wwwn.cdc.gov/nchs/nhanes/nhanes3/default.aspx.
Chalasani N, Younossi Z, Lavine JE, Diehl AM, Brunt EM, Cusi K, Charlton M, Sanyal AJ. 2012. The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association. Hepatology. 55(6):2005–2023.
Cheng R, Barton JC, Morrison ED, Phatak PD, Krawitt EL, Gordon SC, Kowdley KV. 2009. Differences in hepatic phenotype between hemochromatosis patients with HFE C282Y homozygosity and other HFE genotypes. J Clin Gastroenterol. 43(6):569–573.
Cui J, Ang B, Haufe W, Hernandez C, Verna EC, Sirlin CB, Loomba R. 2015. Comparative diagnostic accuracy of magnetic resonance elastography vs. eight clinical prediction rules for non-invasive diagnosis of advanced fibrosis in biopsy-proven non-alcoholic fatty liver disease: a prospective study. Aliment Pharmacol Ther. 41(12):1271–1280.
Drury TF, Winn DM, Snowden CB, Kingman A, Kleinman DV, Lewis B. 1996. An overview of the oral health component of the 1988–1991 National Health and Nutrition Examination Survey (NHANES III–Phase 1). J Dent Res. 75 Spec No.:620–630.
Dye BA, Mitnik GL, Iafolla TJ, Vargas CM. 2017. Trends in dental caries in children and adolescents according to poverty status in the United States from 1999 through 2004 and from 2011 through 2014. J Am Dent Assoc. 148(8):550–565.e7.
Dye BA, Tan S, Smith V, Lewis BG, Barker LK, Thornton-Evans G, Eke PI, Beltran-Aguilar ED, Horowitz AM, Li CH. 2007. Trends in oral health status: United States, 1988–1994 and 1999–2004. National Center for Health Statistics. Vital Health Stat. 11(248):1–92.
Eke PI, Thornton-Evans GO, Wei L, Borgnakke WS, Dye BA. 2010. Accuracy of NHANES periodontal examination protocols. J Dent Res. 89(11):1208–1213.
European Association for the Study of the Liver, European Association for the Study of Diabetes, European Association for the Study of Obesity. 2016. EASL-EASD-EASO clinical practice guidelines for the management of non-alcoholic fatty liver disease. Obes Facts. 9(2):65–90.
Fleischman MW, Budoff M, Zeb I, Li D, Foster T. 2014. NAFLD prevalence differs among Hispanic subgroups: the Multi-ethnic Study of Atherosclerosis. World J Gastroenterol. 20(17):4987–4993.
Gotfredsen K, Walls AWG. 2007. What dentition assures oral function? Clin Oral Implants Res. 18 Suppl 3:34–45.
Han P, Sun D, Yang J. 2016. Interaction between periodontitis and liver diseases. Biomed Rep. 5(3):267–276.
Le MH, Devaki P, Ha NB, Jun DW, Te HS, Cheung RC, Nguyen MH. 2017. Prevalence of non-alcoholic fatty liver disease and risk factors for advanced fibrosis and mortality in the United States. PLoS One. 12(3):e0173499.
Li Q, Dhyani M, Grajo JR, Sirlin C, Samir AE. 2018. Current status of imaging in nonalcoholic fatty liver disease. World J Hepatol. 10(8):530–542.
Lonardo A, Ballestri S, Marchesini G, Angulo P, Loria P. 2015. Nonalcoholic fatty liver disease: a precursor of the metabolic syndrome. Dig Liver Dis. 47(3):181–190.
Lustig RH. 2014. Fat chance: beating the odds against sugar, processed food, obesity and disease. New York (NY): PLUME, Penguin Group.
McPherson S, Stewart SF, Henderson E, Burt AD, Day CP. 2010. Simple non-invasive fibrosis scoring systems can reliably exclude advanced fibrosis in patients with non-alcoholic fatty liver disease. Gut. 59(9):1265–1269.
Naka S, Nomura R, Takashima Y, Okawa R, Ooshima T, Nakano K. 2014. A specific Streptococcus mutans strain aggravates non-alcoholic fatty liver disease. Oral Dis. 20(7):700–706.
Naka S, Wato K, Hatakeyama R, Okawa R, Nomura R, Nakano K. 2018. Longitudinal comparison of Streptococcus mutans–induced aggravation of non-alcoholic steatohepatitis in mice. J Oral Microbiol. 10(1):1428005.
Page RC, Eke PI. 2007. Case definitions for use in population-based surveillance of periodontitis. J Periodontol. 78(7 Suppl):1387–1339.
Qiao F, Fu K, Zhang Q, Liu L, Meng G, Wu H, Xia Y, Bao X, Gu Y, Shi H, et al. 2018. The association between missing teeth and non-alcoholic fatty liver disease in adults. J Clin Periodontol. 45(8):941–951.
Ruhl CE, Everhart JE. 2015. Fatty liver indices in the multiethnic United States National Health and Nutrition Examination Survey. Aliment Pharmacol Ther. 41(1):65–76.
Shah AG, Lydecker A, Murray K, Tetri BN, Contos MJ, Sanyal AJ; Nash Clinical Research Network. 2009. Comparison of noninvasive markers of fibrosis in patients with nonalcoholic fatty liver disease. Clin Gastroenterol Hepatol. 7(10):1104–1112.
Softic S, Cohen DE, Kahn CR. 2016. Role of dietary fructose and hepatic de novo lipogenesis in fatty liver disease. Dig Dis Sci. 61(5):1282–1293.
Sterling RK, Lissen E, Clumeck N, Sola R, Correa MC, Montaner J, Sulkowski MS, Torriani FJ, Dieterich DT, Thomas DL, et al; APRICOT Clinical Investigators. 2006. Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection. Hepatology. 43(6):1317–1325.
Westat Inc. 1988. National Health and Nutrition Examination Survey. Gallbladder ultrasonography procedure manual; [accessed 2018 Oct 18]. https://wwwn.cdc.gov/nchs/data/nhanes3/manuals/gallblad.pdf.
Yki-Järvinen H. 2014. Non-alcoholic fatty liver disease as a cause and a consequence of metabolic syndrome. Lancet Diabetes Endocrinol. 2(11):901–910.
Yoneda M, Naka S, Nakano K, Wada K, Endo H, Mawatari H, Imajo K, Nomura R, Hokamura K, Ono M, et al. 2012. Involvement of a periodontal pathogen, Porphyromonas gingivalis on the pathogenesis of non-alcoholic fatty liver disease. BMC Gastroenterol. 12:16.
Younossi ZM, Koenig AB, Abdelatif D, Fazel Y, Henry L, Wymer M. 2016. Global epidemiology of nonalcoholic fatty liver disease: meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology. 64(1):73–84.
Younossi ZM, Loomba R, Anstee QM, Rinella ME, Bugianesi E, Marchesini G, Neuschwander-Tetri BA, Serfaty L, Negro F, Caldwell SH, et al. 2018. Diagnostic modalities for non-alcoholic fatty liver disease (NAFLD), non-alcoholic steatohepatitis (NASH) and associated fibrosis. Hepatology. 68(1):349–360.

Supplementary Material

Supplemental Material

Please find the following supplemental material visualised and available to download via Figshare in the display box below. Where there are more than one item, you can scroll through each tab to see each separate item.

Please note all supplemental material carries the same license as the article it is here associated with

Summary

A supplemental appendix to this article is available online.

Resources

File (ds_10.1177_0022034519866442.pdf)

Cite article

Cite article

Cite article

OR

Download to reference manager

If you have citation software installed, you can download article citation data to the citation manager of your choice

Share options

Share

Share this article

Share with email
EMAIL ARTICLE LINK
Share on social media

Share access to this article

Sharing links are not relevant where the article is open access and not available if you do not have a subscription.

For more information view the Sage Journals article sharing page.

Information, rights and permissions

Information

Published In

Article first published online: August 1, 2019
Issue published: October 2019

Keywords

  1. oral health
  2. periodontitis
  3. tooth loss
  4. dental caries
  5. NHANES
  6. cross-sectional studies

Rights and permissions

© International & American Associations for Dental Research 2019.
Request permissions for this article.
PubMed: 31369716

Authors

Affiliations

J.A. Weintraub
Adams School of Dentistry, University North Carolina at Chapel Hill, Chapel Hill, NC, USA
G. Lopez Mitnik
National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, MD, USA
B.A. Dye
National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, MD, USA

Notes

J.A. Weintraub, Adams School of Dentistry, University North Carolina at Chapel Hill, 4508 Koury Oral Health Sciences Building, Chapel Hill, NC 27599-7450, USA. Email: [email protected]

Metrics and citations

Metrics

Journals metrics

This article was published in Journal of Dental Research.

VIEW ALL JOURNAL METRICS

Article usage*

Total views and downloads: 608

*Article usage tracking started in December 2016


Altmetric

See the impact this article is making through the number of times it’s been read, and the Altmetric Score.
Learn more about the Altmetric Scores



Articles citing this one

Receive email alerts when this article is cited

Web of Science: 26 view articles Opens in new tab

Crossref: 30

  1. Nisin lantibiotic prevents NAFLD liver steatosis and mitochondrial oxi...
    Go to citation Crossref Google Scholar
  2. Fatty liver index (FLI): more than a marker of hepatic steatosis
    Go to citation Crossref Google Scholar
  3. Association of Sleep Duration with Tooth Loss and Periodontitis: Insig...
    Go to citation Crossref Google Scholar
  4. Association between muscle quality index and periodontal disease among...
    Go to citation Crossref Google Scholar
  5. The Association Between Periodontal Disease and Non-Alcoholic Fatty Li...
    Go to citation Crossref Google Scholar
  6. Mediating role of systemic inflammation in the association between hea...
    Go to citation Crossref Google Scholar
  7. Nonalcoholic Fatty Liver Disease as a Systemic Disease and the Need fo...
    Go to citation Crossref Google Scholar
  8. The impact of metabolic disorders on management of periodontal health ...
    Go to citation Crossref Google Scholar
  9. The Presence of Periodontitis Exacerbates Non-Alcoholic Fatty Liver Di...
    Go to citation Crossref Google Scholar
  10. Involvement of Periodontal Disease in the Pathogenesis and Exacerbatio...
    Go to citation Crossref Google Scholar
  11. Periodontal treatment and microbiome-targeted therapy in management of...
    Go to citation Crossref Google Scholar
  12. Plasma elaidic acid level is associated with periodontal health in Ame...
    Go to citation Crossref Google Scholar
  13. The Triangle of Nonalcoholic Fatty Liver Disease, Metabolic Dysfunctio...
    Go to citation Crossref Google Scholar
  14. Periodontal Disease and Nonalcoholic Fatty Liver Disease: New Microbio...
    Go to citation Crossref Google Scholar
  15. Periodontal disease could be a potential risk factor for non-alcoholic...
    Go to citation Crossref Google Scholar
  16. Association between liver cirrhosis and peri-implant diseases: a case-...
    Go to citation Crossref Google Scholar
  17. Periodontal diseases and non-alcoholic fatty liver disease
    Go to citation Crossref Google Scholar
  18. Porphyromonas gingivalis Induces Increases in Branched-Chain Amino Aci...
    Go to citation Crossref Google Scholar
  19. Association between asthma and severe tooth loss in the adult populati...
    Go to citation Crossref Google Scholar
  20. Oral Health and Liver Disease: Bidirectional Associations—A Narrative ...
    Go to citation Crossref Google Scholar
  21. Ligature induced periodontitis in rats causes gut dysbiosis leading to...
    Go to citation Crossref Google Scholar
  22. Deciphering the toxicological role of Porphyromonas gingivalis derived...
    Go to citation Crossref Google Scholar
  23. Periodontal disease–related nonalcoholic fatty liver disease and nonal...
    Go to citation Crossref Google Scholar
  24. Dietary inflammatory potential is associated with poor periodontal hea...
    Go to citation Crossref Google Scholar
  25. Relationship between NAFLD and Periodontal Disease from the View of Cl...
    Go to citation Crossref Google Scholar
  26. Addressing Oral Health Inequities, Access to Care, Knowledge, and Beha...
    Go to citation Crossref Google Scholar
  27. Association of periodontitis and tooth loss with liver cancer: A syste...
    Go to citation Crossref Google Scholar
  28. Rosmarinic acid exerts an antagonistic effect on nonalcoholic fatty li...
    Go to citation Crossref Google Scholar
  29. Is periodontal disease a risk factor for severe COVID-19 illness?
    Go to citation Crossref Google Scholar
  30. Association between periodontal disease, tooth loss and liver diseases...
    Go to citation Crossref Google Scholar

Figures and tables

Figures & Media

Tables

View Options

Get access

Access options

If you have access to journal content via a personal subscription, university, library, employer or society, select from the options below:


Alternatively, view purchase options below:

Purchase 24 hour online access to view and download content.

Access journal content via a DeepDyve subscription or find out more about this option.

View options

PDF/ePub

View PDF/ePub

Full Text

View Full Text